Coronavirus treatment: Gilead says positive data on remdesivir coming - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug

Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

The antiviral drug remdesivir is being tested in several ongoing trials of COVID-19 patients. Gilead stated that one of these studies, run by the US National Institutes of Health, shows the drug works.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 729. in JP

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Coronavirus research: flaws in trials for remdesivir, chloroquine - Business Insider'We have no reliable data' on potential coronavirus treatments, one researcher said. Here's how that could change over the next few weeks.
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »

Coronavirus: EU rewrote coronavirus report after pressure by China - Business InsiderReferences to a Chinese campaign of 'global disinformation' about the coronavirus were removed before publication. China wins again! Shame on EU !
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »

Coronavirus antibody treatments: Eli Lilly, Regeneron, GSK, Amgen - Business Insider4 top drugmakers are studying the body's own efforts to fight off viruses as they race to find a COVID-19 treatment that could be ready by the fall Yaaaaay Yeah seriously, I can't stop itching all over!!!!
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »